SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Spotify Technology SA engages in the provision of digital music services. It operates through the Premium and Ad-Supported segments. The Premium segment provides subscribers with online and offline streaming access of music and podcasts on computers, tablets, and mobile devices. The Ad-Supported segment offers users with limited on-demand online access of music and unlimited online access of podcasts on computers, tablets, and mobile and smart devices. The company was founded by Daniel Ek and Martin Lorentzon on December 27, 2006 and is headquartered in Stockholm, Sweden.

Spotify Technology S.A.

Spotify shares are drawing attention after rising sharply despite a Q3 revenue and EPS miss, with traders focusing instead on premium subscriber growth, stronger gross margin, and an upbeat Q4 operating-income outlook. The move has surprised skeptics, while bullish traders point to the guidance and operating metrics as support for the rally.

Compound (COMP) is a cryptocurrency and operates on the Ethereum platform. Compound has a current supply of 10,000,000 with 9,999,999.99995246 in circulation. The last known price of Compound is 20.49527411 USD and is down -2.02 over the last 24 hours. It is currently trading on 652 active market(s) with $25,001,434.49 traded over the last 24 hours. More information can be found at https://www.compound.xyz/.

Compound

Discussion centers on Compounds institutional push, including its institutional-market launch, new leadership, and plans tied to tokenized assets and DeFi. Traders see these developments as potential growth drivers, while others remain frustrated that COMP has lagged broader crypto and struggled to sustain gains.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regenerons strong third-quarter earnings beat, supported by growth in Dupixent and Eylea HD, is driving a sharp share-price gain and breakout discussion. Traders are broadly bullish on the follow-through and new highs, while some are watching for a pullback or gap retest.

Schwab Strategic Trust - Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF

SCHDs strong performance and fresh highs are drawing attention as traders describe a rotation from volatile tech and AI stocks into dividend-paying value funds for defensive exposure. Long-term holders are celebrating and adding shares, while some caution the rally may be stretched and note that rising Treasury yields can pressure dividend ETFs.

Interactive Brokers Group, Inc. is an investment holding company, which engages in broker or dealer and proprietary trading businesses. It offers custody and service accounts for hedge and mutual funds, exchange-traded funds, registered investment advisors, proprietary trading groups, introducing brokers, and individual investors. The company was founded by Thomas Pechy Peterffy in 1977 and is headquartered in Greenwich, CT.

Interactive Brokers Group Inc - Ordinary Shares - Class A

Interactive Brokers Group Inc 

IBKR is drawing attention after its earnings report prompted a selloff despite growth in client accounts and interest income; traders are focused on weaker trading activity and competition, while others view the firms profitability and dividend increase as positives. The reaction reflects debate over whether slower activity outweighs the companys strong underlying business.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Inovios FDA approval of a competing treatment for recurrent respiratory papillomatosis has put pressure on Precigens PAPZIMEOS and sparked debate over how much competition it will bring. Traders weigh Inovios potential treatment advantages against Precigens commercial head start and full-approval status, while questioning the rivals accelerated-approval and commercialization path.

The Charles Schwab Corp. is a savings and loan holding company, which engages in the provision of wealth management, securities brokerage, banking, asset management, custody, and financial advisory services. It operates through the Investor Services and Advisor Services segments. The Investor Services segment includes retail brokerage, investment advisory, and banking and trust services to individual investors, retirement plan and business services, as well as other corporate brokerage services, to businesses and employees. The Advisor Services segment provides custodial, trading, banking and trust, and support services to independent registered investment advisors, independent retirement advisors, and recordkeepers. The company was founded by Charles Robert Schwab in 1986 and is headquartered in Westlake, TX.

Charles Schwab Corp.

Shares are under pressure after Schwabs Q3 revenue fell slightly short of estimates despite an earnings beat, with traders focused on whether the prolonged decline can hold near $84. Some see an oversold buying opportunity, while others remain concerned about continued weakness and recurring platform outages.

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders such as Parkinson’s disease, metabolic disorders, including thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Abbvie Inc

AbbVies stronger-than-expected third-quarter results and raised 2026 outlook, supported by growth in its immunology portfolio, are driving attention. Traders are weighing the earnings beat against the stocks recent run-up, with some cheering the results and others describing the reaction as profit-taking or sell the news.

NEOS ETF Trust - NEOS Nasdaq 100 High Income ETF

NEOS Nasdaq 100 High Income ETF

A broader market and technology-stock selloff is weighing on QQQI, prompting many income-focused traders to buy the dip while others are moving to cash or questioning the funds downside and NAV risks. The discussion also centers on its monthly option-income distributions and the trade-off between cash flow and capped upside.

Carpenter Technology Corp. engages in the manufacturing, fabrication, and distribution of specialty metals. It operates through the Specialty Alloys Operations and Performance Engineered Products segments. The Specialty Alloys Operations segment is composed of its major premium alloy and stainless-steel manufacturing operations. The Performance Engineered Products segment includes the Dynamet titanium, Carpenter Additive, and the Latrobe and Mexico distribution businesses. The company was founded by James Carpenter in 1889 and is headquartered in Philadelphia, PA.

Carpenter Technology Corp.

Carpenter Technologys latest quarterly report has sparked a sharp selloff despite profit coming in above expectations: revenue missed, the full-year outlook was maintained, and higher capital spending weighed on free cash flow. Bulls call the drop an oversold reaction to strong aerospace and defense demand, while bears focus on the cautious outlook and cash-flow pressure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Asana Announces Board Appointments

Asana, Inc. (NYSE: ASAN), the operating system for human-agent teams, today announced that Dan Rogers has been appointed Board Chair, a role he will hold in addition to Chief Executive Officer, effective September 25, 2026. The company also announced the appointments of Jerry Ting and Tom Berquist...

Why Asana Stock Flailed on Friday

Key PointsIt beat on both the top and bottom lines while growing both fundamentals...

Notable Two Hundred Day Moving Average Cross - ASAN

In trading on Friday, shares of Asana Inc (Symbol: ASAN) crossed below their 200 day moving average of $8.83, changing hands as low as $8.32 per share. Asana Inc shares are currently trading off about 13.3% on the day. The chart below shows the one year performance of ASAN sha...

Asana to Present at Upcoming Investor Events

Asana, Inc. (NYSE: ASAN)(LTSE: ASAN), the operating system for human-agent teams, today announced that Asanas executives will present at the following investor events:Citi's 2026 Global TMT Conference on September 9, 2026 at 7:10 a.m. PT / 10:10 a.m. ETPiper Sandler Growth Frontiers Conference on...

Asana CEO on solving the AI agent coordination problem

Asana CEO on solving the AI agent coordination problem...

These Analysts Increase Their Forecasts On Asana Following Upbeat Q2 Results

Asana beats Q2 estimates and raises full-year revenue guidance, but offers soft Q3 EPS outlook; shares fall 14% as analysts lift price targets.read more...

Futures, Yields Flat Ahead Of August Jobs Report

Futures, Yields Flat Ahead Of August Jobs Report

 US futures are choppy, trading between unchanged and modestly higher, ahead of today's jobs report which sees a modest increase in August payrolls (but the risk is for another negative print, see our preview here). As of 8:00am ET, S&P...

Oxford Industries Posts Mixed Q2 Results, Joins Asana, Lululemon Athletica And Other Big Stocks Moving Lower In Friday's Pre-Market Session

U.S. futures mixed; Oxford Industries fell 12.6% after mixed results. Lululemon, Guidewire, Asana and UiPath also dropped premarket.read more...

Transcript: Asana Q2 2027 Earnings Conference Call

On Thursday, Asana (NYSE:ASAN) discussed second-quarter financial results during its earnings call. The full transcript is provided below.
This content is powered by Benzinga APIs. For comprehensive financial data andread more...

Asana, Inc. (ASAN) Q2 Earnings and Revenues Top Estimates

Asana (ASAN) delivered earnings and revenue surprises of +11.11% and +1.09%, respectively, for the quarter ended July 2026. Do the numbers hold clues to what lies ahead for the stock?

Asana, Inc. engages in the business of developing a work management platform that helps organizations orchestrate work from daily tasks to cross-functional strategic initiatives. The company was founded by Dustin Moskovitz and Justin Michael Rosenstein on December 16, 2008 and is headquartered in San Francisco, CA.

Asana Inc - Ordinary Shares - Class A

Opendoor Bull Eric Jackson Shorts CRM, DOCU, TEAM, FIVE, ASAN – Here’s Why

Equity

Bearish Sentiment

<ul class="summary-bullets"><li>Jackson said he tested the theory on over 700 earnings calls over the last two decades.</li><li>The hedge fund manager argued that many SaaS companies are overvalued and vulnerable, as&nbsp;they are trading largely on AI hype.</li><li>Stocktwits sentiment was ‘bearish’ for TEAM, CRM, ASAN and DOCU, and ‘neutral’ for FIVE.</li></ul>Hedge fund manager and crypto entrepreneur Eric Jackson on Tuesday revealed short positions in Salesforce, Five9, DocuSign, Atlassian, and Asana — backed by a provocative thesis: the companies talking most about AI tend to deliver the weakest forward returns.Jackson, best known for his bullish Opendoor call, said he analyzed 147 earnings call transcripts across 21 enterprise software firms, then expanded the study to 716 SaaS earnings calls spanning the past two decades to test the idea.<h2 class="st-heading-2">‘AI Paradox’</h2>“The result: companies in the top quintile of AI language density underperformed the bottom quintile by 5.4 percentage points over the following 90 days,” Jackson said in his&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://eventhorizoniq.substack.com/p/im-short-asana-salesforce-five9-docusign?r=1iiu0&amp;utm_campaign=post&amp;utm_medium=web&amp;triedRedirect=true">Substack blog</a>, calling the trend the “AI Paradox.”He argued that certain SaaS companies are overvalued and vulnerable because their growth narratives are increasingly driven by AI hype rather than underlying demand, masking a broader slowdown in core business momentum.&nbsp;Those companies are facing weakening organic growth, rising customer acquisition costs, and deteriorating pricing power, especially as enterprise spending tightens.&nbsp;“Chegg was a $14 billion company. Management said "AI is an opportunity." Stock went from $115 to $0.67. The same language pattern is now showing up in five enterprise software companies,” he said in an&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/ericjackson/status/2038981167311896616?s=20">X thread</a> about his blog. He&nbsp;added that certain companies, such as CrowdStrike, Zscaler, and Palo Alto, are benefiting as well, with AI making their products “more necessary, not less.”But, “the market is punishing both groups equally. That's the mistake.”<h2 class="st-heading-2">Jackson’s SAAS Shorts Already In Doldrums</h2>To be sure, all the companies Jackson has shorted are trading at multi-year lows. Asana shares are at&nbsp;their lowest point on record, while Atlassian stock was the biggest loser on Nasdaq in the first quarter of 2026. CRM declined nearly 30% last quarter, its worst since the 2008 financial crisis.Jackson, who runs EMJ Capital and a&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/opendoor-bull-eric-jackson-picks-a-rather-dull-time-to-launch-his-crypto-treasury-firm/cLeOWwDREpU">crypto treasury company</a>, last month said he had&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/opendoor-bull-eric-jackson-turns-attention-to-palantir/cZbimd7R4lX">invested in Palantir</a> after the AI company's blowout fourth-quarter results. He has previously&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/opendoor-bull-eric-jackson-picks-a-rather-dull-time-to-launch-his-crypto-treasury-firm/cLeOWwDREpU">taken long positions</a> on Carvana, Better Home &amp; Finance, IREN, and BTQ Technologies, among others.On Stocktwits, the retail sentiment was ‘bearish’ for TEAM, CRM, ASAN and DOCU, and ‘neutral’ for FIVE on Tuesday.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/mrvl-on-sndk-lead-chip-stock-rally-as-trump-signals-iran-war-nearing-end/cZ7H77fRIn4">MRVL, ON, SNDK Lead Chip Stock Rally As Trump Signals Iran War Nearing End</a>

A trader checking stock market charts. Hedge fund manager Eric Jackson said he shorted SAAS stocks. (Picture source: Getty Images)

After combing through hundreds of software earnings calls, Jackson’s takeaway is simple: the more a company leans into AI talk, the worse its stock tends to perform.

Asana Inc

Salesforce Inc

DocuSign Inc

Five Below Inc

Opendoor Technologies Inc

Atlassian Corporation Plc

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$11.23
Prev Close	$11.26
Open	$11.26
Dividend Yield	0.00%
50-Day Moving Average	$9.81
Beta	1.62
Avg. Volume	9.08M
PE Ratio	-17.19

52-Week High	$15.28
52-Week Low	$5.38
Market Capitalization	$2.57B
EPS (Annual)	-$0.7982
Price to Book	24.83
Revenue Per Employee	$447,541.60

Feed

News

Sentiment

Earnings

Fundamentals

Info

ASAN Fundamentals